Transarterial chemoembolisation is the standard of care for intermediate stage (BCLC B) hepatocellular carcinoma, but it is challenging to decide when to repeat or stop treatment. | Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma